ANX-042 / Mayo Clinic, Anexon 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ANX-042 / Anexon
ANX-042 Aim 1, NCT03019653: Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

Enrolling by invitation
1
60
US
ANX-042, Placebo
Mayo Clinic, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Heart Failure, Cardiorenal Disease, Renal Disfunction
12/24
12/24

Download Options